Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001818331-25-000023
Filing Date
2025-02-20
Accepted
2025-02-20 08:09:23
Documents
5
Effectiveness Date
2025-02-20

Document Format Files

Seq Description Document Type Size
1 S-8 wgs-sx8february2025evergre.htm S-8 101398
2 EX-FILING FEES genedx-sx8ex107filingfeeta.htm EX-FILING FEES 23137
3 EX-5.1 genedx-51opinionforsx82025.htm EX-5.1 14097
4 EX-23.1 rprt05-formsx8consent.htm EX-23.1 2687
5 image_0a.jpg GRAPHIC 9607
  Complete submission text file 0001818331-25-000023.txt   155965
Mailing Address 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902
Business Address 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902 888-729-1206
GeneDx Holdings Corp. (Filer) CIK: 0001818331 (see all company filings)

EIN.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285080 | Film No.: 25643352
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)